Cargando…

Antisense Tissue Factor Oligodeoxynucleotides Protected Diethyl Nitrosamine/Carbon Tetrachloride-Induced Liver Fibrosis Through Toll Like Receptor4-Tissue Factor-Protease Activated Receptor1 Pathway

Tissue factor (TF) is a blood coagulation factor that has several roles in many non-coagulant pathways involved in different pathological conditions such as angiogenesis, inflammation and fibrogenesis. Coagulation and inflammation are crosslinked with liver fibrosis where protease-activated receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Shouman, Maha M., Abdelsalam, Rania M., Tawfick, Mahmoud M., Kenawy, Sanaa A., El-Naa, Mona M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144514/
https://www.ncbi.nlm.nih.gov/pubmed/34045968
http://dx.doi.org/10.3389/fphar.2021.676608
_version_ 1783696975412068352
author Shouman, Maha M.
Abdelsalam, Rania M.
Tawfick, Mahmoud M.
Kenawy, Sanaa A.
El-Naa, Mona M.
author_facet Shouman, Maha M.
Abdelsalam, Rania M.
Tawfick, Mahmoud M.
Kenawy, Sanaa A.
El-Naa, Mona M.
author_sort Shouman, Maha M.
collection PubMed
description Tissue factor (TF) is a blood coagulation factor that has several roles in many non-coagulant pathways involved in different pathological conditions such as angiogenesis, inflammation and fibrogenesis. Coagulation and inflammation are crosslinked with liver fibrosis where protease-activated receptor1 (PAR1) and toll-like receptor4 (TLR4) play a key role. Antisense oligodeoxynucleotides are strong modulators of gene expression. In the present study, antisense TF oligodeoxynucleotides (TFAS) was evaluated in treating liver fibrosis via suppression of TF gene expression. Liver fibrosis was induced in rats by a single administration of N-diethyl nitrosamine (DEN, 200 mg/kg; i. p.) followed by carbon tetrachloride (CCl4, 3 ml/kg; s. c.) once weekly for 6 weeks. Following fibrosis induction, liver TF expression was significantly upregulated along with liver enzymes activities and liver histopathological deterioration. Alpha smooth muscle actin (α-SMA) and transforming growth factor-1beta (TGF-1β) expression, tumor necrosis factor-alpha (TNF-α) and hydroxyproline content and collagen deposition were significantly elevated in the liver. Blocking of TF expression by TFAS injection (2.8 mg/kg; s. c.) once weekly for 6 weeks significantly restored liver enzymes activities and improved histopathological features along with decreasing the elevated α-SMA, TGF-1β, TNF-α, hydroxyproline and collagen. Moreover, TFAS decreased the expression of both PAR1 and TLR4 that were induced by liver fibrosis. In conclusion, we reported that blockage of TF expression by TFAS improved inflammatory and fibrotic changes associated with CCl4+DEN intoxication. In addition, we explored the potential crosslink between the TF, PAR1 and TLR4 in liver fibrogenesis. These findings offer a platform on which recovery from liver fibrosis could be mediated through targeting TF expression.
format Online
Article
Text
id pubmed-8144514
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81445142021-05-26 Antisense Tissue Factor Oligodeoxynucleotides Protected Diethyl Nitrosamine/Carbon Tetrachloride-Induced Liver Fibrosis Through Toll Like Receptor4-Tissue Factor-Protease Activated Receptor1 Pathway Shouman, Maha M. Abdelsalam, Rania M. Tawfick, Mahmoud M. Kenawy, Sanaa A. El-Naa, Mona M. Front Pharmacol Pharmacology Tissue factor (TF) is a blood coagulation factor that has several roles in many non-coagulant pathways involved in different pathological conditions such as angiogenesis, inflammation and fibrogenesis. Coagulation and inflammation are crosslinked with liver fibrosis where protease-activated receptor1 (PAR1) and toll-like receptor4 (TLR4) play a key role. Antisense oligodeoxynucleotides are strong modulators of gene expression. In the present study, antisense TF oligodeoxynucleotides (TFAS) was evaluated in treating liver fibrosis via suppression of TF gene expression. Liver fibrosis was induced in rats by a single administration of N-diethyl nitrosamine (DEN, 200 mg/kg; i. p.) followed by carbon tetrachloride (CCl4, 3 ml/kg; s. c.) once weekly for 6 weeks. Following fibrosis induction, liver TF expression was significantly upregulated along with liver enzymes activities and liver histopathological deterioration. Alpha smooth muscle actin (α-SMA) and transforming growth factor-1beta (TGF-1β) expression, tumor necrosis factor-alpha (TNF-α) and hydroxyproline content and collagen deposition were significantly elevated in the liver. Blocking of TF expression by TFAS injection (2.8 mg/kg; s. c.) once weekly for 6 weeks significantly restored liver enzymes activities and improved histopathological features along with decreasing the elevated α-SMA, TGF-1β, TNF-α, hydroxyproline and collagen. Moreover, TFAS decreased the expression of both PAR1 and TLR4 that were induced by liver fibrosis. In conclusion, we reported that blockage of TF expression by TFAS improved inflammatory and fibrotic changes associated with CCl4+DEN intoxication. In addition, we explored the potential crosslink between the TF, PAR1 and TLR4 in liver fibrogenesis. These findings offer a platform on which recovery from liver fibrosis could be mediated through targeting TF expression. Frontiers Media S.A. 2021-05-11 /pmc/articles/PMC8144514/ /pubmed/34045968 http://dx.doi.org/10.3389/fphar.2021.676608 Text en Copyright © 2021 Shouman, Abdelsalam, Tawfick, Kenawy and El-Naa. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Shouman, Maha M.
Abdelsalam, Rania M.
Tawfick, Mahmoud M.
Kenawy, Sanaa A.
El-Naa, Mona M.
Antisense Tissue Factor Oligodeoxynucleotides Protected Diethyl Nitrosamine/Carbon Tetrachloride-Induced Liver Fibrosis Through Toll Like Receptor4-Tissue Factor-Protease Activated Receptor1 Pathway
title Antisense Tissue Factor Oligodeoxynucleotides Protected Diethyl Nitrosamine/Carbon Tetrachloride-Induced Liver Fibrosis Through Toll Like Receptor4-Tissue Factor-Protease Activated Receptor1 Pathway
title_full Antisense Tissue Factor Oligodeoxynucleotides Protected Diethyl Nitrosamine/Carbon Tetrachloride-Induced Liver Fibrosis Through Toll Like Receptor4-Tissue Factor-Protease Activated Receptor1 Pathway
title_fullStr Antisense Tissue Factor Oligodeoxynucleotides Protected Diethyl Nitrosamine/Carbon Tetrachloride-Induced Liver Fibrosis Through Toll Like Receptor4-Tissue Factor-Protease Activated Receptor1 Pathway
title_full_unstemmed Antisense Tissue Factor Oligodeoxynucleotides Protected Diethyl Nitrosamine/Carbon Tetrachloride-Induced Liver Fibrosis Through Toll Like Receptor4-Tissue Factor-Protease Activated Receptor1 Pathway
title_short Antisense Tissue Factor Oligodeoxynucleotides Protected Diethyl Nitrosamine/Carbon Tetrachloride-Induced Liver Fibrosis Through Toll Like Receptor4-Tissue Factor-Protease Activated Receptor1 Pathway
title_sort antisense tissue factor oligodeoxynucleotides protected diethyl nitrosamine/carbon tetrachloride-induced liver fibrosis through toll like receptor4-tissue factor-protease activated receptor1 pathway
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144514/
https://www.ncbi.nlm.nih.gov/pubmed/34045968
http://dx.doi.org/10.3389/fphar.2021.676608
work_keys_str_mv AT shoumanmaham antisensetissuefactoroligodeoxynucleotidesprotecteddiethylnitrosaminecarbontetrachlorideinducedliverfibrosisthroughtolllikereceptor4tissuefactorproteaseactivatedreceptor1pathway
AT abdelsalamraniam antisensetissuefactoroligodeoxynucleotidesprotecteddiethylnitrosaminecarbontetrachlorideinducedliverfibrosisthroughtolllikereceptor4tissuefactorproteaseactivatedreceptor1pathway
AT tawfickmahmoudm antisensetissuefactoroligodeoxynucleotidesprotecteddiethylnitrosaminecarbontetrachlorideinducedliverfibrosisthroughtolllikereceptor4tissuefactorproteaseactivatedreceptor1pathway
AT kenawysanaaa antisensetissuefactoroligodeoxynucleotidesprotecteddiethylnitrosaminecarbontetrachlorideinducedliverfibrosisthroughtolllikereceptor4tissuefactorproteaseactivatedreceptor1pathway
AT elnaamonam antisensetissuefactoroligodeoxynucleotidesprotecteddiethylnitrosaminecarbontetrachlorideinducedliverfibrosisthroughtolllikereceptor4tissuefactorproteaseactivatedreceptor1pathway